Using advanced computational genomics, Johns Hopkins investigators discovered how prostate cancer develops resistance to ...

Sir Chris Hoy’s stage-four diagnosis has put prostate cancer under the spotlight among cyclists. Cycling Weekly tackles the ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you need to know about who can get checked ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Burley Brewton was able to count on a new advancement in targeted therapy after he was diagnosed with prostate cancer, the ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...

The NHS does not offer routine prostate cancer screening for all men. The PSA (prostate-specific antigen) test, which measures a protein produced by the prostate, is mainly available for men with ...

Prostate cancer was found in 23% of men whose initially abnormal PSA levels fell to below 4 ng/mL. Men whose PSA levels rise above 4 ng/mL—a commonly used threshold for prostate biopsy—but then ...